☰

Rebekah J. Jakel, Ph.D. - Publications

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
visual working memory, attention, dynamical systems approaches to cognition
Tree Info Grants Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, Chen PC. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Annals of the New York Academy of Sciences. 1147: 61-9. PMID 19076431 DOI: 10.1196/Annals.1427.036  0.686
2007 Jakel RJ, Townsend JA, Kraft AD, Johnson JA. Nrf2-mediated protection against 6-hydroxydopamine. Brain Research. 1144: 192-201. PMID 17336276 DOI: 10.1016/J.Brainres.2007.01.131  0.722
2007 Johnson JA, Johnson DA, Lee JM, Li J, Kraft AD, Calkins MJ, Jakel RJ. The Nrf2-ARE pathway: A potential therapeutic target for neurodegenerative diseases International Congress Series. 1302: 143-153. DOI: 10.1016/j.ics.2006.10.026  0.643
2005 Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA. Nrf2, a multi-organ protector? Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1061-6. PMID 15985529 DOI: 10.1096/Fj.04-2591Hyp  0.608
2005 Jakel RJ, Kern JT, Johnson DA, Johnson JA. Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro. Toxicological Sciences : An Official Journal of the Society of Toxicology. 87: 176-86. PMID 15976186 DOI: 10.1093/Toxsci/Kfi241  0.597
2005 Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proceedings of the National Academy of Sciences of the United States of America. 102: 244-9. PMID 15611470 DOI: 10.1073/Pnas.0408487101  0.712
2004 Jakel RJ, Schneider BL, Svendsen CN. Using human neural stem cells to model neurological disease. Nature Reviews. Genetics. 5: 136-44. PMID 14735124 DOI: 10.1038/Nrg1268  0.339
2000 Maragos WF, Jakel R, Chesnut D, Pocernich CB, Butterfield DA, St Clair D, Cass WA. Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase. Brain Research. 878: 218-22. PMID 10996156 DOI: 10.1016/S0006-8993(00)02707-4  0.378
2000 Jakel RJ, Maragos WF. Neuronal cell death in Huntington's disease: a potential role for dopamine. Trends in Neurosciences. 23: 239-45. PMID 10838590 DOI: 10.1016/S0166-2236(00)01568-X  0.459
1999 Maragos WF, Jakel RJ, Chesnut MD, Geddes JW, Dwoskin LP. Does dopamine contribute to striatal damage caused by impaired mitochondrial function? Annals of the New York Academy of Sciences. 893: 345-9. PMID 10672263 DOI: 10.1111/J.1749-6632.1999.Tb07851.X  0.377
1999 Maragos WF, Tillman PA, Chesnut MD, Jakel RJ. Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions. Brain Research. 834: 168-72. PMID 10407109 DOI: 10.1016/S0006-8993(99)01487-0  0.307
1999 Kruman II, Nath A, Maragos WF, Chan SL, Jones M, Rangnekar VM, Jakel RJ, Mattson MP. Evidence that Par-4 participates in the pathogenesis of HIV encephalitis. The American Journal of Pathology. 155: 39-46. PMID 10393834 DOI: 10.1016/S0002-9440(10)65096-1  0.321
1998 Maragos WF, Jakel RJ, Pang Z, Geddes JW. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions. Experimental Neurology. 154: 637-44. PMID 9878198 DOI: 10.1006/Exnr.1998.6918  0.389
Show low-probability matches.